{"id":"W2015354352","doi":"10.1586/14737140.5.6.1001","title":"Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects","year":2005,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Antisense therapy; Genetic enhancement; Cancer research; Cancer; Radiation therapy; Cancer therapy; Targeted therapy; Chemotherapeutic drugs; Internal medicine; Gene; Biology; Oligonucleotide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005417407,0.0007334118,0.001084456,0.001311793,0.0002350656,0.0006896546,0.0005971048,0.0009599664,0.00302893],"category_scores_gemma":[0.0003533529,0.000193541,0.0003855055,0.00136324,0.0003083046,0.0009129846,0.000327162,0.001024703,0.001589428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000416432,"about_ca_system_score_gemma":0.0006950513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007886912,"about_ca_topic_score_gemma":0.001955135,"domain_scores_codex":[0.9998804,0.00002568782,0.00001763381,0.00002145131,0.00004332895,0.00001134577],"domain_scores_gemma":[0.9998304,0.00008365413,0.00002578584,0.000003838095,0.00003912823,0.00001725017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001242648,0.0001731523,0.0002303539,0.01151744,0.0000692296,0.0005287344,0.00006885469,0.0006185869,0.009790949,0.002651397,0.0137617,0.9604653],"study_design_scores_gemma":[0.00005345348,0.0003920365,0.001113237,0.00256582,0.0001825319,0.003321962,0.00009667173,0.0003182454,0.003763346,0.002442203,0.9857185,0.00003186613],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002452092,0.9982875,0.0002761509,0.0001859352,0.0001091953,0.000004318406,0.00000765686,0.000006520946,0.0008775764],"genre_scores_gemma":[0.0009237186,0.9978732,0.0003831675,0.0001379666,0.0001161772,0.000006935766,0.00001369775,0.000001325541,0.0005437934],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00302893,"threshold_uncertainty_score":0.01013279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04421512318308846,"score_gpt":0.416129422003612,"score_spread":0.3719142988205235,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}